स्मार्ट शोधा! ब्रँड किंवा जेनेरिक नाव

तुमचा ब्रँड शोधा आणि त्याचे जेनेरिक पर्याय सहज मिळवा!

शोधा
  • TELMISARTAN 40 MG
  • AMLODIPINE 5 MG
  • VILDAGLIPTIN 50 MG
  • TRAMADOL 50 MG INJECTION
  • CALCIUM 500 MG
  • VITAMIN D3 250 IU
  • PANTOPRAZOLE 40 MG
  • ATORVASTATIN 10 MG
  • ASPIRIN 75 MG
  • BUSESONIDE 0.5 MG
  • DOMPERIDONE(PR) 30 MG
  • HYDROCHOLROTHIAZIDE 12.5 MG
  • METOPROLOL 25 MG ER
  • ROSUVASTATIN 10 MG
  • DAPAGLOZIN 10 MG
  • VOGLIBOSE 0.2 MG
  • OMEGA-3 FATTY ACID
  • GLIMEPIRIDE 1 MG
  • ATENOLOL 50 MG
  • METFORMIN HYDROCHLORIDE 500 MG

ट्रेंडिंग शोध: व्हिटॅमिन D, अमोक्सिसिलिन, आयुष, अ‍ॅबॉट

Tofacitinib Extended Release 11 Mg Tablet
औषध उत्पादन

Tofacitinib Extended Release 11 Mg Tablet

Tofacitinib Extended-Release 11 mg Tablet contains Tofacitinib 11 mg in an extended-release formulation. It is a Janus kinase (JAK) inhibitor used to treat moderate to severe rheumatoid arthritis, psoriatic arthritis, and ulcerative colitis in appropriate patients. It helps reduce inflammation, relieve symptoms, and improve physical function through once-daily dosing.

₹ 422.00 58% सवलत

एमआरपी: ₹ 999.00  *सर्व करांसह

USP: Rs. 42.20 / TAB

पॅक आकार STRIP OF 10 TAB
रचना TOFACITINIB EXTENDED RELEASE 11 MG
प्रॉडक्ट कोड GMP2359
व्ह्यूज 4728

स्टॉकमध्ये उपलब्ध

100% अस्सल
सुरक्षित पेमेंट
जलद डिलिव्हरी
सोपा परतावा

ग्राहकांनी हेही खरेदी केले »

डब्ल्यूएचओ-जीएमपी प्रमाणित उत्पादन
गुणवत्ता नियंत्रण अहवाल उपलब्ध
100% अस्सल उत्पादन

Ratings & Reviews

No reviews yet

Be the first to share your experience with this product.

उत्पादन तपशील

Tofacitinib Extended Release 11 Mg Tablet चा उपयोग
Moderate to severe rheumatoid arthritis (RA) Active psoriatic arthritis (PsA) Moderate to severe ulcerative colitis (UC), where clinically appropriate Patients requiring once-daily extended-release Tofacitinib therapy as determined by the treating physician
How To Use of Tofacitinib Extended Release 11 Mg Tablet
Take the tablet exactly as prescribed by your doctor. Usually taken once daily. It may be taken with or without food. Swallow the extended-release tablet whole with water. Do not crush, chew, split, or break the tablet, as this may affect the extended-release properties. Take the medicine at the same time every day. Do not stop treatment without consulting your doctor.
Storage of Tofacitinib Extended Release 11 Mg Tablet
Store below 30°C.
Side Effects of Tofacitinib Extended Release 11 Mg Tablet
Upper respiratory tract infections Headache Diarrhea Nausea
Contraindications of Tofacitinib Extended Release 11 Mg Tablet
Are allergic to Tofacitinib or any component of the tablet. Have an active serious infection, including active tuberculosis. Have severe liver impairment unless specifically recommended by a specialist.
Safety Advice of Tofacitinib Extended Release 11 Mg Tablet
Use only under the supervision of a qualified healthcare professional. Screening for tuberculosis (TB), hepatitis B, and hepatitis C is recommended before starting treatment. Regular monitoring of complete blood count (CBC), liver function tests, kidney function, and lipid profile is advised. Inform your doctor immediately if you develop fever, persistent cough, unexplained weight loss, or symptoms of infection. Avoid live vaccines while taking Tofacitinib. Inform your healthcare provider about all medicines you are taking, especially biologic DMARDs, immunosuppressants, corticosteroids, and medicines affecting the CYP3A4 enzyme system.
References of Tofacitinib Extended Release 11 Mg Tablet
Tofacitinib Extended-Release Prescribing Information. American College of Rheumatology (ACR). Guideline for the Treatment of Rheumatoid Arthritis. European Alliance of Associations for Rheumatology (EULAR). Recommendations for the Management of Rheumatoid Arthritis. American Gastroenterological Association (AGA). Clinical Practice Guidelines for Ulcerative Colitis. Brunton LL, Hilal-Dandan R, Knollmann BC. Goodman & Gilman's The Pharmacological Basis of Therapeutics.
Mechanism of Tofacitinib Extended Release 11 Mg Tablet
Tofacitinib selectively inhibits Janus kinase (JAK) enzymes, primarily JAK1 and JAK3, with partial inhibition of JAK2. This blocks the JAK-STAT signaling pathway, reducing the activity of multiple inflammatory cytokines involved in autoimmune diseases. As a result, inflammation is suppressed, immune-mediated tissue damage is reduced, and symptoms such as pain, swelling, and stiffness improve. The extended-release formulation provides sustained drug release, enabling convenient once-daily dosing while maintaining therapeutic drug levels.
Therapeutic of Tofacitinib Extended Release 11 Mg Tablet
Janus Kinase (JAK) Inhibitor
Tofacitinib Extended Release 11 Mg Tablet चा उत्पादक

MASCOT HEALTH SERIES PVT. LTD.

PLANT ADDRESS 1 :PLOT NO. 79-80, SECTOR 6A, SIDKUL, HARIDWAR (U.K) PLANT ADDRESS 2 :PLOT NO. 52, SECTOR 6A, IIE, SIDKUL HARIDWAR (U.K), ECTOR 6A, HARIDWAR, HARIDWAR, UTTARAKHAND, 249403, INDIA

Comparison

Brand Genericart Medicine
औषध EXNIB 11 MG TOFACITINIB EXTENDED RELEASE 11 MG TABLET
रचना TOFACITINIB EXTENDED RELEASE 11 MG TOFACITINIB EXTENDED RELEASE 11 MG
Company ZYDUS CADILA GENERICART MEDICINE
Price ₹ 2250.00 ₹ 422.00
You Save ₹ 1,828.00 (81.24% Less)

अस्वीकरण

At Genericart, our primary goal is to provide information that is thoroughly reviewed, accurate, and reliable. However, it is important to note that the content provided here should not be considered a substitute for professional medical advice. The information presented on our platform is intended for educational purposes only and may not cover all aspects of specific health conditions, medications, potential side effects, drug interactions, warnings, or alerts. We strongly encourage consulting with a qualified healthcare professional for advice and guidance regarding their health concerns and medication needs.

सर्वाधिक ऑर्डर केलेली

आजमावलेले, विश्वासार्ह आणि पुन्हा पुन्हा ऑर्डर केलेले!